CPH Group AG (XSWX:CPHN) Research & Development: CHF0.0 Mil (TTM As of Dec. 2025)


XSWX:CPHN CPH Group AG XSWX:CPHN
61 GF Score
Price CHF55.60
GF Value CHF45.13
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is CPH Group AG Research & Development?

CPH Group AG XSWX:CPHN +0.36% 61 Research & Development is CHF0.0 Mil as of Dec. 2025. GuruFocus rates XSWX:CPHN with a GF Score™ of 61/100 and a GF Value™ of CHF45.13 (Modestly Overvalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. CPH Group AG's Research & Development for the six months ended in Dec. 2025 was CHF0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was CHF0.0 Mil.

CPH Group AG  (XSWX:CPHN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

CPH Group AG Research & Development Related Terms

CPH Group AG Research & Development Historical Data

* Premium members only.

The historical data trend for CPH Group AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CPH Group AG Research & Development Chart

CPH Group AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CPH Group AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XSWX:CPHN
61GF Score
CPH Group AG XSWX:CPHN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CPH Group AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of CHF0.0 Mil mean?
CPH Group AG (XSWX:CPHN) has a Research & Development of CHF0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on CPH Group AG and its competitors.
Is CPH Group AG's Research & Development too high?
CPH Group AG's current Research & Development is CHF0.0 Mil. Overall, CPH Group AG has a GF Score™ of 61/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CPH Group AG's Research & Development compare to SLVM?
CPH Group AG's Research & Development of CHF0.0 Mil can be compared against companies in the Forest Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Forest Products company?
A good Research & Development depends on the Forest Products industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on CPH Group AG and its competitors. CPH Group AG's current Research & Development is CHF0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CPH Group AG stock overvalued right now?
Based on GuruFocus' analysis, CPH Group AG (XSWX:CPHN) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF45.13, compared to a current price of CHF55.60 — trading 23.2% above its estimated fair value. The current Research & Development is CHF0.0 Mil. CPH Group AG's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For CPH Group AG (XSWX:CPHN), the current Research & Development is CHF0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CPH Group AG (XSWX:CPHN) Overvalued in 2026?

Based on GuruFocus' analysis, CPH Group AG stock appears to be overvalued. The current stock price of CHF55.60 is trading 23.2% above its estimated GF Value™ of CHF45.13. GuruFocus considers CPH Group AG to be Modestly Overvalued.

Key valuation signals for XSWX:CPHN:

  • Research & Development: CHF0.0 Mil
  • GF Value™: CHF45.13 vs. price of CHF55.60 (23.2% above fair value)
  • GF Score™: 61/100 with 2 warning signs

No single metric tells the full story. See the XSWX:CPHN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CPH Group AG Business Description

Other Exchanges CPHNz:UK0QNZ:UK1L6:Germany
Address Perlenring 1, Perlen, CHE, 6035
CPH Group AG manufactures chemicals, paper, and pharmaceutical packaging films. The business activity of the group is broken down into two divisions, namely Zeochem (chemistry) and Perlen Packaging (packaging). The Zeochem develops, manufactures and supplies a wide range of first-class products in growth markets. These include high-quality molecular sieves for purifying natural gas and ethanol as well as lithium-based oxygen concentration for industrial and medical purposes. Perlen Packaging is the supplier of packaging materials that focuses exclusively on the pharmaceutical industry offering a comprehensive range of pharmaceutical packaging, e.g. films with optimal barrier effect and complementary primary packaging for medications such as vials and containers.
61GF Score

Get the complete analysis for XSWX:CPHN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF55.60
Price
CHF45.13
GF Value